Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neurofibromatosis 1 5Breast Neoplasms 4Prostatic Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Radiation Injuries 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Noonan Syndrome 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Melanoma 1Leukemia, Myeloid, Acute 1Learning Disabilities 1Laryngeal Neoplasms 1Inhibition, Psychological 1Hypopharyngeal Neoplasms 1Dyslexia 1Cognition Disorders 1Carcinoma, Ovarian Epithelial 1Carcinoma 1Breast Carcinoma In Situ 1Autism Spectrum Disorder 1

Interventions

Radiotherapy 24Radiotherapy, Intensity-Modulated 8Radiosurgery 6Amifostine 5Low-Level Light Therapy 4Donepezil 4Cisplatin 4Carboplatin 4Surveys and Questionnaires 3Radiation 3Proton Therapy 3Paclitaxel 3Neuropsychological Tests 3Heavy Ion Radiotherapy 3Etoposide 3Chemotherapy, Adjuvant 3Chemoradiotherapy 3Brachytherapy 3Bevacizumab 3Surgical Procedures, Operative 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Mental Status and Dementia Tests 2Esophagectomy 2Androgen Antagonists 2Adrenal Cortex Hormones 2sodium propionate 1sargramostim 1olaparib 1endostar protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Radiation Injuries × Lovastatin × Clear all
NCT00902668 2013-06-20

Lovastatin in Reducing Side Effects After Radiation Therapy in Women With Breast Cancer

Virginia Commonwealth University

Phase 2 Terminated
3 enrolled 4 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡